Inception | $50,000,000 | (Nov 7, 2025)
SiteLabs | $2,000,000 | (Nov 7, 2025)
DealMaker | $20,000,000 | (Nov 7, 2025)
Certified by Founder
Lodge
Sionna Therapeutics
start up
United States
- Boston, MA
- 07/03/2024
- Series C
- $182,000,000
We are a life sciences company that is building on over a decade of extensive research on the genetic mutations associated with cystic fibrosis. We are developing first-in-class small molecules that are focused on a unique target with the potential to fully normalize CFTR function for the first time for the vast majority of people living with CF.
- Industry Biotechnology
- Website https://www.sionnatx.com/
- LinkedIn https://www.linkedin.com/company/sionna-therapeutics/
Flint(US) | $15,000,000 | (Nov 7, 2025)
Subtle Computing | $6,000,000 | (Nov 7, 2025)
IndustrialMind.ai | $1,200,000 | (Nov 7, 2025)
Fintary | $10,000,000 | (Nov 7, 2025)
Graymatter Labs | $1,300,000 | (Nov 7, 2025)
Avallon AI (YC X25) | $4,600,000 | (Nov 7, 2025)
Kaizen Labs | $12,000,000 | (Nov 7, 2025)
Giga | $61,000,000 | (Nov 7, 2025)
Reevo | $80,000,000 | (Nov 7, 2025)